Ding, Yangfeng, and Weida Liu. 2026. “Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients With Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparisons”. Acta Dermato-Venereologica 106 (April):adv-2025. https://doi.org/10.2340/actadv.v106.adv-2025-0183.